Does LIPEGFILGRASTIM Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with LIPEGFILGRASTIM. This represents 1.4% of all adverse event reports for LIPEGFILGRASTIM.
6
Reports of Malignant neoplasm progression with LIPEGFILGRASTIM
1.4%
of all LIPEGFILGRASTIM reports
0
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LIPEGFILGRASTIM?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIPEGFILGRASTIM. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LIPEGFILGRASTIM Cause?
Neutropenia (60)
Thrombocytopenia (55)
Febrile neutropenia (44)
General physical health deterioration (44)
Pyrexia (37)
Diarrhoea (34)
Anaemia (30)
Dyspnoea (26)
Leukopenia (26)
Headache (25)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LIPEGFILGRASTIM Alternatives Have Lower Malignant neoplasm progression Risk?
LIPEGFILGRASTIM vs LIPITOR
LIPEGFILGRASTIM vs LIRAGLUTIDE
LIPEGFILGRASTIM vs LISDEXAMFETAMINE
LIPEGFILGRASTIM vs LISDEXAMFETAMINE DIMESYLATE
LIPEGFILGRASTIM vs LISINOPRIL